Stanford University
Showing 7,611-7,620 of 12,904 Results
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
BioDr. Montine is the Stanford Medicine Endowed Professor, Chair of Stanford Pathology Department, and member of the National Academy of Medicine. He received his education and medical training at Columbia University, McGill University, and Duke University, and was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology at the University of Washington where he was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and founding Director of the Pacific Udall Center, a NINDS-funded Center of Excellence for Parkinson’s Disease Research. Dr. Montine was Chair of the Department of Pathology at the University of Washington from 2010 to 2016 when he was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain.
